REMINDER: Disease-Modifying Anti-Rheumatic Drug Therapy for Rheumatoid Arthritis Tip Sheets Available
Date: 10/14/20
Superior HealthPlan is committed to helping practitioners improve their quality scores on Healthcare Effectiveness Data and Information Set (HEDIS®) measures. As a reminder, tip sheets are available for the Allwell from Superior HealthPlan Dual Special Needs Plan (D-SNP) and Allwell Medicare Advantage Prescription Drug Plan (MAPD), as well as the STAR+PLUS Medicare-Medicaid Plan (MMP). These tip sheets were designed to assist your practice with increasing HEDIS rates.
These tip sheets outline key aspects of the Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapy for Rheumatoid Arthritis (RA) HEDIS measure, as well as codes associated with this measure and guidance for proper documentation for compliance.
To view the DMARD Therapy for RA Tip Sheets, please review:
- Allwell Dual Special Needs Plan (D-SNP) Tip Sheet (PDF)
- Allwell Medicare Advantage Prescription Drug Plan (MAPD) Tip Sheet (PDF)
- STAR+PLUS Medicare-Medicaid Plan (MMP) Tip Sheet (PDF)
More Information on Rheumatoid Arthritis
RA is one of the most common causes of disability among adults in the United States, especially individuals with multiple chronic conditions. The Arthritis Foundation indicates about 1.5 million people in the United States have RA, and nearly three times as many women have the disease as men. RA is a serious autoimmune inflammatory disease that results in joint damage, pain and disability that can be modified with appropriate treatment. Centers for Medicare & Medicaid Services (CMS) considers DMARD therapy in patients with RA an important quality measure that should be monitored.
Current guidelines from the American College of Rheumatology (ACR) recommend DMARDs should be started for most patients, since early treatment has been shown to slow disease progression, reduce joint damage and improve long-term outcomes. Formulary options for DMARDs include methotrexate, hydroxychloroquine, sulfasalazine and leflunomide. To review the full Allwell formulary, please visit Superior’s Pharmacy webpage.
Contact Us
If you have questions about the tip sheet, or wish to speak with a Superior pharmacist, please contact the Superior Pharmacy Department by phone at 1-800-218-7453, ext. 22272, or email at SHP_PharmacyMedicare@centene.com.